|
78
|
276
|
3vfmA |
Crystal structure of hla b*3508 lpep155a, hla mutant ala155 |
|
78
|
276
|
3vfuA |
Crystal structure of hla b*3508 lpep-p7ala, peptide mutant p7-ala |
|
71
|
275
|
3v5hA |
Hla-a2.1 kvaeivhfl |
|
78
|
276
|
3vfsA |
Crystal structure of hla b*3508lpep-p5ala , peptide mutant p5-ala |
|
77
|
276
|
3vfpA |
Crystal structure of hla b*3508 lpep158g, hla mutant gly158 |
|
78
|
275
|
3vclA |
Crystal structure of hla-b7 with the hcmv pp65 peptide rpherngftvl |
|
78
|
276
|
3vftA |
Crystal structure of hla b*3508lpep-p6ala, peptide mutant p6-ala |
|
79
|
276
|
3utqA |
Human hla-a*0201-alwgpdpaaa |
|
66
|
275
|
3uttA |
1e6-a*0201-alwgpdpaaa complex, triclinic |
|
77
|
281
|
3ubxA |
Crystal structure of the mouse cd1d-c20:2-agalcer-l363 mab fab complex |
|
72
|
276
|
3utsA |
1e6-a*0201-alwgpdpaaa complex, monoclinic |
|
61
|
270
|
3tzvC |
Crystal structure of an inkt tcr in complex with cd1d-lysophosphatidylcholine |
|
71
|
274
|
3tvmA |
Structure of the mouse cd1d-smc124-inkt tcr complex |
|
56
|
175
|
3tjhA |
42f3-p3a1/h2-ld complex |
|
77
|
292
|
3to4A |
Structure of mouse valpha14vbeta2-mousecd1d-alpha-galactosylceramide |
|
70
|
293
|
3tn0A |
Structure of mouse va14vb8.2nkt tcr-mouse cd1d-a-c-galactosylceramide complex |
|
73
|
275
|
3to2A |
Structure of hla-a*0201 complexed with peptide md3-c9 derived from a clustering region of restricted cytotoxic t lymphocyte epitope from sars-cov m protein |
|
49
|
177
|
3tpuE |
42f3 p5e8/h2-ld complex |
|
64
|
275
|
3tbtA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (v3p, y4s) |
|
76
|
273
|
3ta3A |
Structure of the mouse cd1d-glc-dag-s2-inkt tcr complex |
|
64
|
275
|
3tbsA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex the with lcmv-derived gp33 altered peptide ligand (v3p,y4a) |
|
63
|
274
|
3tbwA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (a2g, v3p, y4s) |
|
52
|
174
|
3tfkA |
42f3-p4b10/h2-ld |
|
73
|
277
|
3tieA |
Crystal structure of the vaccinia derived peptide a11r in complex with the murine mhc class i h-2 kb |
|
67
|
276
|
3tbvA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (a2g,v3p,y4a) |
|
64
|
275
|
3tbyA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (v3p, y4f) |
|
49
|
175
|
3tf7A |
42f3 ql9/h2-ld complex |
|
68
|
277
|
3tidA |
Crystal structure of the lcmv derived peptide gp34 in complex with the murine mhc class i h-2 kb |
|
76
|
273
|
3t1fA |
Crystal structure of the mouse cd1d-glc-dag-s2 complex |
|
72
|
275
|
3t8xA |
Crystal structure of human cd1b in complex with synthetic antigenic diacylsulfoglycolipid sgl12 and endogenous spacer |
|
75
|
276
|
3skoA |
Crystal structure of the hla-b8-a66-flr, mutant a66 of the hla b8 |
|
81
|
276
|
3spvA |
Crystal structure of a peptide-hla complex |
|
52
|
277
|
3sjvA |
Crystal structure of the rl42 tcr in complex with hla-b8-flr |
|
80
|
276
|
3skmA |
Crystal structure of the hla-b8flrgrayvl, mutant g8v of the flr peptide |
|
75
|
290
|
3sddA |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-beta-lactosylceramide |
|
76
|
289
|
3sdcA |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-globotrihexosylceramide |
|
80
|
290
|
3sdaA |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-beta-galactosylceramide |
|
78
|
289
|
3scmA |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-isoglobotrihexosylceramide |
|
68
|
275
|
3sdxA |
Crystal structure of human autoreactive-valpha24 nkt tcr in complex with cd1d-beta-galactosylceramide |
|
80
|
391
|
3s6cA |
Structure of human cd1e |
|
76
|
289
|
3rugA |
Crystal structure of valpha10-vbeta8.1 nkt tcr in complex with cd1d-alphaglucosylceramide (c20:2) |
|
68
|
276
|
3rweA |
Rhesus macaque mhc class i molecule mamu-b*17-fw9 |
|
71
|
276
|
3rwhA |
Rhesus macaque mhc class i molecule mamu-b*17-mf8 |
|
69
|
276
|
3rwjA |
Rhesus macaque mhc class i molecule mamu-b*17-hw8 |
|
80
|
276
|
3rwgA |
Rhesus macaque mhc class i molecule mamu-b*17-mw9 |
|
72
|
276
|
3rwiA |
Rhesus macaque mhc class i molecule mamu-b*17-gw10 |
|
73
|
276
|
3rwdA |
Rhesus macaque mhc class i molecule mamu-b*17-iw11 |
|
71
|
276
|
3rwfA |
Rhesus macaque mhc class i molecule mamu-b*17-qw9 |
|
72
|
276
|
3rwcA |
Crystal structure of rhesus macaque mhc class i molecule mamu-b*17-iw9 |
|
67
|
274
|
3rl2A |
Hiv nef derived peptide nef73 complexed to hla-a*0301 |
